Baba Agencies Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Baba Agencies Pharmaceutical Export Portfolio Dataset — 3 Products, $2.7M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Baba Agencies — Pharmaceutical Exporter Profile (2026) | 3 Products, $2.7M Trade | TransData Nexus

Product Portfolio — Top 3 by Export Value

Baba Agencies exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Kit	Medical Devices & Diagnostics	$2.5M	49	0.6%	12
2	Tofacitinib	Advanced Oncology	$163.4K	14	4.1%	3
3	Niacin	Lipid & Metabolism	$64.6K	19	1.7%	6

Baba Agencies exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $2.7M. The top category is Medical Devices & Diagnostics (91.5% of portfolio), followed by Advanced Oncology (6.1%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Baba Agencies — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Baba Agencies is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2010, the company is headquartered in Nagaur, Rajasthan, India. It operates as a privately held entity, with Om Prakash Goyal serving as the proprietor. The company has demonstrated consistent growth, achieving a total export value of $2.7 million USD over 82 shipments from 2022 to 2026. Baba Agencies exports three products across three therapeutic categories, with its top five products accounting for 100% of its portfolio concentration. The company employs a dedicated team committed to maintaining high standards in product quality and customer service.

2Manufacturing Facilities

Baba Agencies operates manufacturing facilities in Nagaur, Rajasthan, India. These facilities are equipped to produce a range of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company emphasizes quality control and adheres to stringent manufacturing practices to ensure the safety and efficacy of its products. While specific production capacities are not publicly disclosed, Baba Agencies has demonstrated the ability to fulfill a significant number of export shipments, indicating robust manufacturing capabilities.

3Key Leadership

Om Prakash Goyal serves as the proprietor of Baba Agencies. Under his leadership, the company has expanded its export operations and established a reputation for delivering quality pharmaceutical products. The leadership team is committed to upholding the company's values of quality, consistency, and customer satisfaction. While detailed information about other key executives is not publicly available, the company's growth and market presence reflect effective management and strategic direction.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Baba Agencies Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Baba Agencies has established a presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and market access in these regions, ensuring compliance with international standards for pharmaceutical exports. Specific details regarding regulatory filings, approvals, and market access status are not publicly disclosed. However, the company's consistent export performance and adherence to quality standards suggest a strong commitment to meeting the regulatory requirements of these markets.

2Emerging Markets

Baba Agencies has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's adherence to WHO prequalification standards has facilitated access to these regions, enabling it to supply quality pharmaceutical products to a broader global audience. While specific market penetration details are not publicly available, the company's export data indicates a strategic approach to diversifying its market presence and catering to the growing demand for pharmaceutical products in these regions.

3Geographic Strategy

Baba Agencies — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Baba Agencies' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. However, the company's consistent export performance to regulated markets suggests compliance with international standards and a commitment to quality assurance. Baba Agencies' adherence to WHO prequalification standards further indicates its dedication to meeting global regulatory requirements.

2WHO & EU GMP

Baba Agencies' adherence to WHO prequalification standards facilitates access to international markets, including those requiring compliance with Good Manufacturing Practice (GMP) guidelines. While specific certifications such as EU GMP are not publicly disclosed, the company's export data and market presence suggest a commitment to maintaining high manufacturing standards. The company's focus on quality control and regulatory compliance underscores its dedication to producing safe and effective pharmaceutical products.

3CDSCO & Indian Regulatory

Baba Agencies — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Baba Agencies operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific competitors are not publicly disclosed, the company's export data indicates a focus on markets such as Malaysia, Africa, Latin America, and Southeast Asia. The company's adherence to WHO prequalification standards and commitment to quality manufacturing practices position it favorably in these markets. Baba Agencies' strategic diversification and focus on emerging markets enable it to effectively compete and capture market share in the global pharmaceutical export industry.

2Key Differentiators

Baba Agencies' key differentiators include its specialization in finished pharmaceutical formulations, adherence to WHO prequalification standards, and a diversified export portfolio across multiple therapeutic categories. The company's commitment to quality control and regulatory compliance ensures the safety and efficacy of its products. Baba Agencies' strategic focus on emerging markets and its ability to meet international standards position it as a competitive player in the global pharmaceutical export sector.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Baba Agencies as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Baba Agencies has demonstrated a strong track record in pharmaceutical exports, with a total export value of $2.7 million USD over 82 shipments from 2022 to 2026. The company's export data indicates consistency and reliability in fulfilling international orders. Baba Agencies' adherence to WHO prequalification standards and commitment to quality manufacturing practices further enhance its reliability as a supplier. The company's strategic diversification into emerging markets and focus on regulatory compliance underscore its dedication to maintaining a positive reputation in the global pharmaceutical export industry.

2Certifications to Verify

Importers should verify the following certifications when considering partnerships with Baba Agencies:

WHO Prequalification: Ensures that the company's products meet international quality standards.

EU GMP Certification: Indicates compliance with European Good Manufacturing Practice guidelines.

Frequently Asked Questions — Baba Agencies

How many pharmaceutical products does Baba Agencies export from India?

Baba Agencies exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Kit ($2.5M), Tofacitinib ($163.4K), Niacin ($64.6K). Total export value is $2.7M.

What is Baba Agencies's total pharmaceutical export value?

Baba Agencies's total pharmaceutical export value is $2.7M, based on 82 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Baba Agencies cover?

Baba Agencies exports across 3 therapeutic categories. The largest are Medical Devices & Diagnostics (91.5%, 1 products), Advanced Oncology (6.1%, 1 products), Lipid & Metabolism (2.4%, 1 products).

Get Full Baba Agencies Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Baba Agencies

Baba Agencies — Export Portfolio & Destination Treemap

Who is Baba Agencies? — Company Overview & Market Position

What Does Baba Agencies Export? — Product Portfolio Analysis

Top Products by Export Value

Baba Agencies Therapeutic Categories — 3 Specializations